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Spinophilin, a dendritic spine-enriched scaffold pro-
tein, modulates synaptic transmission via multiple
functionsmediated by distinct domains of the protein.
Here, we show that spinophilin is a key modulator of
opiateaction.Knockoutof thespinophilingenecauses
reduced sensitivity to the analgesic effects of mor-
phine and early development of tolerance but a higher
degree of physical dependence and increased sensi-
tivity to the rewarding actions of the drug. At the cellu-
lar level, spinophilin associates with the m opioid
receptor (MOR) in striatum and modulates MOR sig-
naling and endocytosis. Activation of MOR by opiate
agonists such as fentanyl and morphine promotes
these events, which feedback to suppress MOR re-
sponsiveness. Our findings support a potent physio-
logical role of spinophilin in regulating MOR function
and provide a potential new target for the treatment
of opiate addiction.
INTRODUCTION
Repeated exposure to opiates leads to addiction, characterized
by drug craving, compulsive drug use, dependence, and analge-
sic tolerance (Koob et al., 1998; Kreek, 2001; De Vries and Ship-
penberg, 2002; Inturrisi, 2002). At the cellular level, opiates exert
their effects via G protein-coupled receptors, primarily the m
opioid receptor (MOR) (Contet et al., 2004). Several proteins, in-
cluding adenylyl cyclases, G protein receptor kinases (GRKs),
b-arrestins, and regulators of G protein signaling (RGS proteins),
have been shown to play a role in different aspects of opiate ac-
tion by modulating the signaling duration and desensitization of
MORs (Li et al., 2006; Terman et al., 2004; Marker et al., 2004;
Bohn et al., 2000; Zachariou et al., 2003; Kim et al., 2006). Among
the best characterized cellular adaptations to chronic opiate
exposure are upregulation of cAMP signal transduction, changes
in the rate of opioid receptor endocytosis, and altered ERK238 Neuron 58, 238–247, April 24, 2008 ª2008 Elsevier Inc.activation (Nestler and Aghajanian, 1997; Law and Loh, 1999; von
Zastrow et al., 2003). However, the timing and cellular specificity
of these responses in the brain have yet to be understood.
Growing evidence indicates that the actions of proteins which
modulate G protein-coupled receptor signaling are dramatically
affected by their binding partners and the multiprotein com-
plexes that they form under specific physiological conditions.
Consequently, molecules such as b-arrestin-2 may promote or
inhibit receptor signaling depending on other factors (Wang
et al., 2004). Our hypothesis is that repeated opiate exposure
leads to adaptations that promote deleterious actions of opiate
drugs (craving, dependence, tolerance) by preventing the forma-
tion of multiprotein complexes necessary for properMOR signal-
ing. Therefore, optimizing the action of proteins that are essential
for the function of such complexes may delay the progress of
addiction.
Spinophilin, a ubiquitously expressed, dendritic spine-en-
riched protein (Allen et al., 1997) interacts with several elements
of the G protein-coupled receptor signaling network, including
protein phosphatase 1 (PP1), RGS proteins, and dopamine D2
receptors (Hsieh-Wilson et al., 1999; Wang et al., 2005; Smith
et al., 1999). Recent studies revealed that spinophilin modulates
a2-adrenergic responses by blocking association of GRK2 with
the agonist-receptor-Gbg complex and, therefore, by antagoniz-
ing b-arrestin-2 function (Richman et al., 2001; Brady et al., 2003;
Wang et al., 2004). Since MORs share many of their signal trans-
duction pathways with a2 receptors (i.e., both are Gi linked), it is
likely that spinophilin plays a role in MOR signal transduction
and desensitization and, consequently, in opiate addiction. Neu-
rabin is a structural analog of spinophilin, with PPI and F-actin
binding properties, and a similar pattern of distribution (Burnett
et al., 1998; Terry-Lorenzo et al., 2002). A major difference
between the two proteins is that spinophilin contains two PKA
phosphorylation sites (Ser-94 and Ser-117) and a receptor
binding/interacting domain (aa 169–255) that are absent from
neurabin (Allen et al., 1997; Richman et al., 2001; Hsieh-Wilson
et al., 1999).
The goal of the present study was to determine the influence
of spinophilin on the acute and chronic actions of opiates. We
relied on the analysis of spinophilin and neurabin knockout
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ioral paradigms. We show that spinophilin, but not neurabin,
plays a prominent physiological role in regulating behavioral
responses to opiates by opposing the development of depen-
dence and tolerance and by decreasing sensitivity to the re-
warding actions of the drugs. We also show that spinophilin af-
fects MOR functional responses by promoting endocytosis and
by inhibiting MOR signaling. Furthermore, our data indicate that
opiate drugs induce association of spinophilin with MOR in
striatum by promoting the formation of complexes between
spinophilin and GRK2, RGS9-2, and Gb subunits, signal trans-
duction molecules that are essential for MOR signaling and
desensitization.
RESULTS
Regulation of Spinophilin Levels by Opiate
Exposure In Vivo
As a first step to investigate the role of spinophilin in physiolog-
ical responses to opiates, we administered several MOR ago-
nists to mice, at doses which produce maximal analgesic re-
sponses in behavioral tests, and monitored spinophilin levels in
the nucleus accumbens, the ventral portion of the striatumwhich
is important for many opiate actions. Table 1 shows regulation of
spinophilin levels, measured by immunoblotting, in the nucleus
accumbens two hrs after administration of different MOR
agonists. Spinophilin is downregulated in this brain region by
acute morphine (20 mg/kg, i.p.) administration. A similar effect
was observed in response to acute administration of other opioid
agonists, such as methadone (20 mg/kg, i.p) and fentanyl
(0.25 mg/kg, s.c.). Our initial working hypothesis was that down-
regulation of spinophilin following acute opiate administration is
one of the cellular adaptations that contribute to MOR desensi-
tization. Interestingly, exposure to opiates has no effect on
neurabin levels and administration of the a2-adrenergic agonist
clonidine does not affect spinophilin levels in the nucleus accum-
bens at the 2 hr time point (Table 1). In contrast to the effects of
acute morphine exposure, chronic morphine has no effect on
spinophilin or neurabin levels in this brain region (not shown).
Loss of spinophilin regulation by chronic morphine may be inter-
preted as one of the adaptive changes that follow continuous
morphine use.
Table 1. Acute Opiate Administration Regulates Spinophilin
Levels in Nucleus Accumbens
Acute
Morphine
Acute
Methadone
Acute
Fentanyl
Acute
Clonidine
Spinophilin levels
(% control)
62 ± 8.9* 80.8 ± 3.3* 73 ± 9.5* 109 ± 17
Neurabin levels
(% control)
106 ± 2.8 115 ± 9.4 111 ± 5.6
Decreased levels of spinophilin (but not of neurabin) in the nucleus ac-
cumbens of C57Bl/6 mice 2 hr after acute morphine (20 mg/kg), metha-
done (20 mg/kg), or fentanyl (0.250 mg/kg) administration. In contrast,
clonidine administration had no significant effect on spinophilin levels in
this brain region. Data represent % change from saline control and are
expressed as means ± SEM, n = 4–5 per group, *p < 0.05 from control
by t test.Behavioral Responses to Opiates in Spinophilin
Knockout Mice
To gain insight into the influence of spinophilin on opioid receptor
function, we investigated morphine analgesia in the 52C hot
plate assay in mice lacking the spinophilin gene. As shown in
Figure 1A, spinophilin mutants are less sensitive to low doses
of morphine in this assay compared to their wild-type littermate
controls. The spinophilin knockout mice are similarly less sensi-
tive to the analgesic actions ofmethadone and fentanyl in this as-
say (Figures 1B and 1C). These findings suggest that spinophilin
may be a positive regulator of analgesic responses to opiate
drugs. We next tested the effect of spinophilin knockout on an-
algesic responses to a nonopiate drug, namely, the a2-adrener-
gic receptor agonist, clonidine. It has been shown previously that
spinophilin is a negative modulator of a2-adrenergic receptor
responses (Wang et al., 2004). Consistent with these earlier
data, we found that spinophilin mutant mice are more sensitive
to the analgesic effects of clonidine (Figure 1D). These findings
show that spinophilin modulates analgesic responses in a recep-
tor selective manner: it is a positive modulator of MOR actions,
but a negative modulator of a2-adrenergic actions.
To assess the role of spinophilin in the development of analge-
sic tolerance, we used the 52C hot plate assay and monitored
morphine effects once a day for 4 consecutive days. Under these
conditions, mice show a gradually reduced response to mor-
phine due to development of tolerance and, by day 4, they
show no analgesic response to a constant dose of the drug.
Interestingly, spinophilin knockout mice develop maximal toler-
ance following a single exposure to morphine, as they show no
response to the drug by day 2 of the hot plate assay (Figure 1E).
To confirm that this is a morphine-related phenotype, we used
the same paradigm and administered the a2 adrenergic agonist,
clonidine. In contrast to what we observed with morphine, anal-
gesic responses to clonidine (0.4 mg/kg) remained unchanged in
both genotypes over 3 days of testing (%MPE for wild-type, day
1 = 25 ± 7, day 2 = 23 ± 3, day 3 = 39 ± 10; %MPE for knockout,
day 1 = 58 ± 7, day 2 = 64 ± 3, day 3 = 70 ± 10). Notably, neurabin
knockout mice develop tolerance to morphine at the same rate
as their wild-type littermate controls (Figure 1F). These latter
data show that rapid development of tolerance is not a general
feature of depletion of proteins containing PP1 interacting/F-ac-
tin binding domains. Furthermore, the facilitated tolerance seen
in spinophilin knockout mice does not reflect a general learning
phenomenon, since initial analgesic responses are reduced
and the mice show no abnormality in the Morris water maze
(not shown).
In addition to tolerance, chronic exposure to opiates causes
severe physical dependence. The role of spinophilin in opiate
physical dependence and withdrawal was evaluated using
a standard morphine withdrawal paradigm. Mice were treated
chronically with increasing doses of morphine, and withdrawal
was precipitated by administration of the opioid receptor antag-
onist, naloxone (1 mg/kg, s.c.). Several signs of opiate with-
drawal were monitored for 25 min after naloxone administration.
We found that the intensity of withdrawal is2-fold higher in spi-
nophilin knockout mice compared to their wild-type controls for
most of the signs monitored (Figure 2A). In contrast, no signifi-
cant difference in opiate withdrawal behavior was observedNeuron 58, 238–247, April 24, 2008 ª2008 Elsevier Inc. 239
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Spinophilin Modulates Opiate AddictionFigure 1. Spinophilin Knockout Mice
Exhibit Decreased Sensitivity to the Analge-
sic Actions of Morphine and Accelerated
Development of Analgesic Tolerance
(A) Spinophilin (SP) knockout (KO) mice show
reduced analgesic responses to low morphine
doses in the 52C hot plate test compared to their
wild-type littermates (SP WT).
(B and C) Dose responses to other opiate drugs,
such as methadone and fentanyl, also shift to the
right in the absence of the spinophilin gene.
(D) In contrast to morphine, spinophilin knockout
mice are more sensitive to the analgesic effects
of clonidine.
(E) Wild-type mice develop tolerance to the anal-
gesic effects of morphine after four daily injections
(20 mg/kg, i.p.), while the spinophilin knockout
mice develop tolerance to morphine much earlier
and show no analgesic response by the second
exposure to the drug.
(F) Neurabin (NB) knockout mice develop toler-
ance to morphine at the same rate as their wild-
type controls. Responses are expressed as %
maximal possible effect (MPE = [Latency-base-
line]/[cutoff latency]). Data are expressed as
means ± SEM, *p < 0.05 for genotype over treat-
ment, two-way ANOVA followed by Bonferroni
test.between neurabin knockout andwild-typemice. In fact, for some
of thewithdrawal signs, therewas a trend formilder withdrawal in
the neurabin mutants. However, this effect was significant only
for weight loss (e.g., jumps for wild-type = 76.2 ± 34, for knock-
out = 22 ± 14; wet dog shakes for wild-type = 6 ± 2.6, for knock-
out = 3.6 ± 1.1; diarrhea for wild-type = 9 ± 1, for knockout = 5 ±
1.8; weight loss for wild-type = 3.9 ± 0.54, for knockout = 1.78 ±
0.38*, n = 7–8 per group, p < 0.05, two way ANOVA followed by
Bonferroni test). These data suggest that spinophilin plays an
important physiological role opposing the development of
morphine dependence.
We next examined the influence of spinophilin on the reward-
ing actions of morphine using the place preference paradigm, in
which animals learn to prefer an environment paired with drug
exposure. In this test, knockout of spinophilin increases the sen-
sitivity of animals to morphine reward (Figure 2B). No differences
were observed between neurabin knockout mice and their wild-
type controls in this paradigm—place preference scores (in s) for
wild-type were as follows: saline =64 ± 57, morphine (5 mg/kg,
i.p.) = 284 ± 67, morphine (10 mg/kg, i.p.) = 390 ± 69; knockout
were as follows: saline =68 ± 24,morphine (5mg/kg, i.p.) = 240 ±
39, morphine (10mg/kg, i.p.) = 272 ± 37. The opposite pheno-
type was observed using a model of spinophilin overexpression
in the nucleus accumbens. C57Bl/6 mice overexpressing spino-
philin in the nucleus accumbens 3 weeks after bilateral stereo-
taxic injection of an AAV-spinophilin vector (which causes
a 78% ± 23% increase in spinophilin protein levels selectively
in this brain region determined by immunoblotting), show re-
duced sensitivity to morphine place conditioning (5 mg/kg,
s.c.) compared to AAV-GFP injected control mice (Figure 2C).
These data specifically relate the altered behavioral sensitivity
to morphine seen in spinophilin knockout mice to the nucleus240 Neuron 58, 238–247, April 24, 2008 ª2008 Elsevier Inc.accumbens per se and argue against the involvement of a devel-
opmental abnormality in this phenomenon.
Finally, we examined the influence of spinophilin in the loco-
motor activating effects of morphine (10 mg/kg, s.c.). In this
test, deletion of the spinophilin gene results in increased locomo-
tor responses to acute and repeated morphine administration
(Figure 2F). In contrast, viral-mediated overexpression of spino-
philin in the nucleus accumbens does not affect the acute loco-
motor activating effect of morphine but prevents the develop-
ment of locomotor sensitization to repeated drug exposure
(Figure 2E).
Deletion of the spinophilin gene does not alter opioid receptor
levels in nucleus accumbens, as determined by specific binding
of [3H]-DAMGO, a highly selective MOR ligand, in striatal mem-
branes of wild-type and knockout mice: wild-type = 109.15 ±
15 fmols/mg protein, knockout = 99.9 ± 13 fmols/mg protein.
In addition, MOR mRNA levels (measured using real time PCR
and expressed as fold change over control) in this brain region
are unaffected by the loss of spinophilin: wild-type = 1 ± 0.06
and knockout = 0.85 ± 0.26. Likewise, striatal levels of pro-
teins involved in MOR responses, such as RGS9-2, RGS4,
b-arrestin-2, and Gb5, determined by immunoblotting, are also
not different in nucleus accumbens between wild-type and
knockout mice (not shown).
Influence of Spinophilin on Cellular Responses
to Opiates In Vitro and In Vivo
We used coimmunoprecipitation to investigate the effect of opi-
ate drugs on the formation of complexes between spinophilin
and MOR in mouse striatum. These studies revealed that under
basal conditionsMOR is associated with spinophilin and that this
association is greatly enhanced 30 min after s.c. administration
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found that activation of MOR promotes the association of spino-
philin with GRK2 (Figure 3B) andwith Gb5 (Figure 3C). In fact, ex-
posure to opiates promotes the formation of spinophilin com-
plexes with all Gb subunits in striatum (not shown). As Gb5 is
a binding partner of the striatal-enriched protein RGS9-2, we ex-
amined whether RGS9-2 is also coprecipitated with spinophilin
after stimulation of MOR. As expected, the spinophilin-RGS9-2
Figure 2. Spinophilin Knockout Mice Exhibit Enhanced Morphine
Reward, Physical Dependence, and Locomotor Activation
(A) Spinophilin (SP) knockout (KO) mice show a much higher degree of mor-
phine dependence, as signs of naloxone (1 mg/kg, s.c.) precipitated opiate
withdrawal are twice as intense in KO mice compared to their wild-type litter-
mates (SP WT, n = 8–9 per group).
(B) Spinophilin knockout mice are also more sensitive to the rewarding effects
of morphine in the place preference test (n = 10–12 per group).
(C) On the other hand, overexpression of spinophilin in the nucleus accumbens
of C57/Bl6 mice using AAV-spinophilin decreases sensitivity to the rewarding
actions of morphine (5 mg/kg, s.c.) in this paradigm compared to AAV-GFP in-
jected control mice (n = 6–8 per group.) Data are expressed as means ± SEM,
*p < 0.05 for genotype over treatment, two-way ANOVA followed by Bonferroni
test.
(D) Low-power (103) magnification of immunofluorescence for GFP, showing
the AAV-GFP vector targeting the nucleus accumbens.
(E) Spinophilin ko mice display greater locomotor responses to acute and
repeated morphine administration than their wild-type littermates (n = 5 per
group).
(F) On the contrary, overexpression of spinophilin in the nucleus accumbens of
C57/Bl6 mice via infection with AAV-Spinophilin does not affect the locomotor
activating effects of acute morphine but prevents the development of locomo-
tor sensitization (n = 5 per group). Data are expressed as means ± SEM,
*p < 0.05 for genotype versus treatment, two-way ANOVA followed by Bonfer-
roni post hoc test.complex is greatly enhanced in striatum following fentanyl or
morphine treatment (Figure 3D).
We next investigated the effect of loss of spinophilin on signal
transduction events that follow activation of MOR. For this pur-
pose, we monitored how the loss of spinophilin affects MOR en-
docytosis, inhibition of adenylyl cyclase, and ERK phosphoryla-
tion, all three being well-characterized responses to acute MOR
activation (Nestler and Aghajanian, 1997; Law and Loh, 1999;
von Zastrow et al., 2003; Eitan et al., 2003; Muller andUnterwald,
2004). We first monitored the effect of morphine on ERK phos-
phorylation and inhibition of cAMP formation in striatum of spino-
philin knockout mice and their wild-type littermates. As
expected, systemic administration of morphine increases
phosphoERK levels in wild-type striatum at 20 min but causes
Figure 3. MOR Coimmunoprecipitates with Spinophilin
(A) Mice were treated with morphine (15 mg/kg) or fentanyl (0.125 mg/kg) for
30 min. Striatal extracts were immunoprecipitated (IP) with an anti-spinophilin
antibody, and the immunoprecipitate was immunoblotted (IB) for MOR. MOR
was immunoprecipitated with spinophilin under basal conditions, and this
interaction was strengthened following acute fentanyl or morphine treatment.
(B) Activation of MOR similarly increases association of spinophilin with GRK2
(B), Gb5 (C), and RGS9-2 (D). Mice were treated with fentanyl or morphine as in
(A), and striatal extracts were immunoprecipitated for spinophilin and immuno-
blotted for GRK2, Gb5, or RGS9-2, respectively. For all experiments, data are
expressed as means ± SEM, n = 3 per treatment group, Sal = saline treatment,
Fent = fentanyl treatment, Morph = morphine treatment, SP KO = striata from
morphine treated spinophilin KO mice, Ctr (Control) = striata from morphine-
treated mice immunoprecipitated with an anti-Flag antiserum.Neuron 58, 238–247, April 24, 2008 ª2008 Elsevier Inc. 241
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of spinophilin (250% of saline in striatum of knockout mice ver-
sus 150% of saline observed in wild-type controls; Figure 4A).
As a control, we monitored phosphoERK levels in striatum
from spinophilin wild-type and knockout mice following saline
or clonidine (0.4 mg/kg) administration. Contrary to observations
Figure 4. Spinophilin Modulates Opiate Regulation of ERK Phos-
phorylation and Adenylyl Cyclase Activity
Spinophilin knockout (KO) mice show greater morphine induction of ERK
phosphorylation in striatum after morphine administration compared to wild-
type littermates (WT). Immunoblot analysis of phosphoERK levels in striatum
of KO and WT mice 20 min after an injection of saline (Sal) or 10 mg/kg mor-
phine (Morph) (A) or after injection of saline or 0.4 mg/kg clonidine (Clon) (B).
n = 4–5 per group, data are expressed asmeans ± SEM, *p < 0.05 for genotype
versus treatment, two-way ANOVA followed by Bonferroni post hoc test.
(C) Striatal membranes (10 mg protein/10 ml) from spinophilin KO and WT
mice were treated with different concentrations of DAMGO (0–10 mM) for
15min at 30C, and the amount of cAMP formedwas determined as described
in Experimental Procedures. Results are the means ± SEM of five individual
animals in triplicate. **p < 0.001, ***p < 0.0005, t test.242 Neuron 58, 238–247, April 24, 2008 ª2008 Elsevier Inc.with morphine, clonidine had no effect of on ERK phosphoryla-
tion in striatum in wild-type (123% ± 20%) or spinophilin knock-
out (86% ± 11%) mice.
In striking contrast to regulation of ERK, spinophilin is required
for opioid inhibition of cAMP formation in striatum: the MOR ag-
onist DAMGO reduces cAMP formation in striatal homogenates
of wild-type mice, an effect not observed in extracts of knockout
mice (Figure 4C).
To evaluate the role of spinophilin inMOR endocytosis, we first
monitored the rate of MOR internalization following exposure to
opiate drugs in the presence or absence of spinophilin in PC12
cells. MOR internalization was quantified using ELISA in PC12
cells transiently transfected with epitope-tagged MOR (HA-
MOR), along with a spinophilin plasmid or empty vector. Under
control conditions, application of the opioid peptide DAMGO
leads to fast internalization of MOR, while morphine application
leads to delayed MOR internalization. As shown in Figure 5A,
overexpression of spinophilin promotesmorphine-inducedMOR
internalization so that the receptor is internalized within 30 min.
Similar results were observed using immunofluorescence to
directly visualize HA-MOR in PC12 cells (Figure 5B).
We next monitored MOR endocytosis in cultured mouse em-
bryonic fibroblasts (MEFs) from spinophilin wild-type and knock-
out embryos using ELISA. We used MEF cultures and not cul-
tured striatal neurons, because homozygous spinophilin
knockout mice do not breed well and, while we were able to ob-
tain sufficient quantities of MEF cells from embryos of heterozy-
gous crosses, it was not possible to derive sufficient quantities of
striatal neurons. MEF cells were infected with a herpes simplex
virus (HSV) vector expressing HA-MOR (HSV-HA-MOR) (Haber-
stock-Debic et al., 2003), and drug treatments were applied 24 hr
later. Similar to what was observed previously in striatal cultures
(Haberstock-Debic et al., 2005), both morphine and DAMGO
induce MOR internalization within 30 min in MEF cells. Interest-
ingly, endocytosis is observed within 30 min in wild-type MEFs,
but not in MEFs from spinophilin knockout mice (Figure 5C). In
addition, MEF cells from spinophilin wild-type and knockout
mice were infected with HSV-HA-MOR, and MOR cellular local-
ization was monitored 24 hr later using immunofluorescence. In
wild-type MEFs, MOR is internalized 30 min following morphine
treatment (10 mM), however, no internalization is observed in
MEFs from spinophilin knockout embryos at this time point
(Figure 5D).
We also determined the action of spinophilin in MOR endocy-
tosis in wild-type striatal neurons in primary culture. To knock
down spinophilin expression in the neurons, we transfected
striatal cultures with a small interfering RNA (siRNA) directed
against spinophilin or a control siRNA as described by Wang
et al. (2004). We found that this treatment is effective in reducing
spinophilin protein levels by >75% (24 ± 2 of control; Figure 6A)
as determined by immunoblot analysis. The cells were then in-
fected with HSV-HA-MOR and 24 hr later, HA-MOR localization
was monitored using immunofluorescence. As shown in Fig-
ure 6B, under these conditions, administration of 10 mM mor-
phine causes robust MOR internalization at 30 min in control,
but internalization is significantly delayed in spinophilin siRNA
transfected neurons (mean number of HA-MOR infected
cells in which MOR showed intracellular localization at 30 min:
Neuron
Spinophilin Modulates Opiate AddictionFigure 5. Regulation of MOR Internalization
by Spinophilin
(A) Graph represents percent internalization 30min
following DAMGO (5 mM) or morphine (10 mM)
treatment in PC12 cells transfected with control
vector or spinophilin construct. Internalization
was quantified using ELISA. Data are expressed
as means ± SEM, n = 4–5 per group, *p < 0.05 be-
tween treatments for each group, ANOVA fol-
lowed by PLSD test.
(B) PC12 cells transiently transfected with control
vector and HA-MOR or with spinophilin plasmid
and HA-MORwere treated with saline or morphine
(10 mM) for 30 min. MOR cellular localization was
determined immunofluorescence to the HA tag.
(C) Graph represents percent internalization
30 min following DAMGO or morphine treatment
(as in [A] and [B]) in mouse embryonic fibroblasts
(MEF) from spinophilin (SP) knockout (KO) and
wild-type (WT) 14-day-old embryos infected with
an HSV-HA-MOR vector. Internalization was
quantified using ELISA. Data are expressed as
means ± SEM, n = 4 per group, *p < 0.05 between
treatments for each group, ANOVA followed by
PLSD test.
(D) MEF from SP WT and KO embryos were in-
fected with an HSV-HA-MOR vector and 24 hr
later were treated with saline or morphine (10 mM) for 30 min. MOR cellular localization was detected using immunofluorescence. For immunofluorescence stud-
ies, each set of experiments was repeated three times, and each treatment was performed in duplicate.control siRNA group = 65.9 ± 6.7, spinophilin siRNA group =
34 ± 1.8).
DISCUSSION
Our study provides evidence for an important physiological role
of spinophilin in the regulation of MOR signaling and behavioral
responses to opiate drugs of abuse. Deletion of the spinophilin
gene causes reduced analgesic effects of acute morphine but
enhanced adaptations to repeated morphine exposure, includ-
ing increased morphine dependence, place conditioning, loco-
motor sensitization, and analgesic tolerance. These diverse
effects of spinophilin may result not only from its broad distribu-
tion in the brain, but also from its multiple actions at the cellular
level. Thus, spinophilin modulates MOR responsiveness via
complex mechanisms that promote MOR internalization and re-
cycling as well as MOR inhibition of adenylyl cyclase but oppose
MOR activation of ERK. Our findings offer new insight into the
cellular events underlying chronic opiate action and point to
spinophilin as a promising new target for the optimization of
the analgesic actions of opiate drugs with reduced drug toler-
ance and dependence.
Several studies have implicated signal transduction proteins in
particular aspects of opiate action. Behavioral characterization
of GRK3 knockout mice reveals that GRK3 is involved in analge-
sic tolerance but does not affect other aspects of morphine
action (Terman et al., 2004). Studies of genetic mutant mice sug-
gest that RGS9-2 and b-arrestin-2 each act as a negative mod-
ulator of morphine’s effects (Bohn et al., 2000; Zachariou et al.,
2003). RGS9-2 potently suppresses morphine reward, analge-
sia, and physical dependence, whereas b-arrestin-2 mainly af-
fects analgesic responsiveness and tolerance but not physicaldependence. The fact that b-arrestin-2 mutants show increased
sensitivity to the analgesic effects of morphine but normal re-
sponses to other opioid drugs (Bohn et al., 1999, 2000, 2004), in-
dicates that signal transduction molecules beyond b-arrestin-2
modulate MOR analgesic responses. Our data suggest that spi-
nophilin is one such additional modulator of MOR function, one
that regulates MOR desensitization and affects the actions of
all opiate analgesic drugs. Unlike the other signal transduction
proteins studied to date, genetic ablation of spinophilin causes
opposite effects on morphine reward and dependence versus
analgesic responsiveness, a phenotype that mimics several fea-
tures of addiction (exacerbated withdrawal, locomotor sensitiza-
tion, place conditioning, and tolerance). The only other protein
known to mediate this complex phenotype is the transcription
factor, DFosB, acting in the nucleus accumbens (Zachariou
et al., 2006). However, knockout of spinophilin does not alter
DFosB levels in this brain region, nor doesDFosB regulate spino-
philin expression (Zachariou et al., 2006), suggesting that spino-
philin and DFosB act through distinct mechanisms. Future stud-
ies are needed to determine whether modulation of dopamine
receptor responsiveness by spinophilin, or possible spinal cord-
specific actions of this protein, also contribute to the opiate
phenotype.
Our data demonstrate an essential role of spinophilin in regu-
lating the rate of MOR internalization: reducing spinophilin levels
with siRNA in cultured striatal neurons delays internalization.
Similar effects on MOR internalization are observed in cultured
MEF cells from spinophilin knockout embryos, whereas overex-
pression of spinophilin in cell lines promotes MOR internaliza-
tion. The facilitation of MOR internalization by spinophilin is par-
ticularly dramatic for morphine, which is normally associated
with much slower receptor internalization in cultured cellsNeuron 58, 238–247, April 24, 2008 ª2008 Elsevier Inc. 243
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Spinophilin Modulates Opiate Addictioncompared to that induced by opioid peptides (Keith et al., 1998;
Whistler and von Zastrow, 1998; Whistler et al., 1999). Indeed,
the high levels of expression of spinophilin in striatum could ex-
plain the rapid internalization of MOR observed in response to
morphine in striatal neurons in vivo compared to cultured cells
in vitro (Haberstock-Debic et al., 2003).
Earlier in vitro studies indicated that the rate of MOR endocyto-
sis is a critical factor controlling the development of analgesic tol-
erance (Keith et al., 1998; Whistler and von Zastrow, 1998; Whis-
tler et al., 1999), with reduced endocytosis associated with
exacerbated tolerance. Thus, our findings that knockout of spino-
philin reduces MOR internalization and facilitates tolerance (and
other adaptations to repeatedmorphine exposure) are consistent
with this model. Several more recent studies have provided
important information on themolecular determinants ofMOR en-
docytosis, as well as information on its occurrence in vivo (Hab-
erstock-Debic et al., 2003, 2005; Arttamangkul et al., 2006; Zhao
et al., 2006). It will therefore be important in future studies to
focus on interactions between spinophilin and other regulators
of MOR trafficking and on local manipulation of spinophilin in
particular brain regions, to determine the mechanism via which
this protein modulates MOR function.
Figure 6. Knockout of Spinophilin Delays MOR Internalization
(A) Blot shows spinophilin levels in cultured striatal neurons infected with
control or spinophilin siRNA.
(B) Knockdown of spinophilin expression using siRNA prevents MOR endocy-
tosis in cultured striatal neurons. Neurons were transfected with siRNA for spi-
nophilin or with control siRNA and 48 hr later were infectedwith HSV-HA-MOR.
The next day, cells were treated with morphine (10 mM) for 30, 45, or 60 min,
and MOR internalization was observed using immunofluoresence. While
MOR is internalized within 30 min in striatal neurons transfected with control
siRNA, in neurons transfected with spinophilin siRNA, MOR was internalized
at 60 min.244 Neuron 58, 238–247, April 24, 2008 ª2008 Elsevier Inc.Our behavioral studies reveal that spinophilin knockout mice
show increased sensitivity to the rewarding and locomotor sen-
sitizing actions of morphine. We speculate that this increased
sensitivity could be interpreted as earlier development of motiva-
tional dependence and are therefore consistent with our data on
physical dependence. The increased sensitivity observed in the
place preference test may also be related to interactions be-
tween spinophilin and PP1; however, if this were the case, this
phenotypemight be expected to be observed in neurabin knock-
out mice as well, as neurabin is also a ubiquitous PP1 interacting
protein. Another possiblemechanism viawhich spinophilin could
modulate sensitivity to the rewarding actions of morphine would
involve interactions with G protein Gb subunits. Earlier reports in-
dicated that spinophilin interacts with the bg complex (Brady
et al., 2003; Wang et al., 2004). We show here that exposure to
opiate drugs leads to the rapid association of spinophilin with
Gb5. Gb5 is one of the most abundant G protein b subunits in
brain and, in particular, is enriched in striatum. Gb5 is also an es-
sential binding partner for RGS9, as it contributes to the protein’s
stability (Chen et al., 2003). The striatal-enriched protein, RGS9-
2, is considered a key regulator of MOR responsiveness (Zachar-
iou et al., 2003; Psifogeorgou et al., 2007) and, as expected, it is
found in the same complex with spinophilin after activation of
MOR. This is particularly interesting since lack of either RGS9
or spinophilin increases sensitivity to morphine reward and leads
to more severe dependence. The fact that spinophilin knockout
mice show decreased sensitivity to morphine’s analgesic ef-
fects, whereas RGS9 knockout animals show increased sensitiv-
ity, indicates that modulation of morphine analgesia by spinophi-
lin may involve distinct actions at the cellular level or actions
beyond the nucleus accumbens and dorsal striatum.
Modified ERK phosphorylation and cAMP activity in the brain
have been associated with regulation of morphine reward and
dependence (Nestler, 2001; Valjent et al., 2006). Opioids can in-
crease or decrease ERK phosphorylation depending on the brain
region involved (Eitan et al., 2003; Muller and Unterwald, 2004),
but little information is available concerning the influence of ERK
signaling in the nucleus accumbens on behavioral responses to
morphine. Previous work showed that spinophilin accelerates
ERK phosphorylation in cultured MEF cells after activation of
a2 receptors (Wang et al., 2005). Interestingly, in striatum, knock-
out of spinophilin enhances morphine-induced increases in
phosphoERK. Further work is needed to explore the behavioral
consequences of spinophilin regulation of ERK function in this
brain region. Our studies also demonstrate that knockout of spi-
nophilin reduces the ability of morphine to inhibit adenylyl cy-
clase in striatum, an effect which would be expected to influence
behavioral responses to opiate drugs (Barrot et al., 2002). It is
striking that loss of spinophilin impairs MOR signaling via ad-
enylyl cyclase but enhances MOR signaling via ERK. Opiate in-
hibition of adenylyl cyclase is thought to represent a direct
effect of Gi on the enzyme, whereas the molecular pathway by
which Gi-linked receptors activate the ERK pathway has re-
mained incompletely understood. The opposite effects of spino-
philin on these signaling pathways could provide unique insight
into understanding MOR regulation of cAMP and ERK signaling.
In summary, we show that spinophilin opposes the conse-
quences of repeated opiate exposure and that these actions
Neuron
Spinophilin Modulates Opiate Addictioncould be achieved by promoting MOR internalization and recy-
cling and by modulating signal transduction events that follow
opiate activation of MOR. Spinophilin regulation of MOR is very
different from that observed previously for other receptors.
These findings thereby contribute to our understanding of recep-
tor-selective functions of spinophilin and provide information on
newmolecular elements that regulate MOR responsiveness. The
molecular actions of spinophilin suggest that it could serve as
a new pharmacological target to promote opiate analgesia, while
preventing cellular events that lead to addiction after repeated
exposure to these drugs.
EXPERIMENTAL PROCEDURES
Mouse Breeding and Genotyping
All spinophilin and neurabin mutant mice used in this study (Feng et al., 2000;
Allen et al., 2006) were generated from breedings of heterozygous spinophilin
or neurabin knockout mice. For all behavioral assays, we used naive 2-month-
old male knockout mice and their wild-type littermates. For immunoblotting
analysis, striata from 2-month-old C57Bl/6 mice were extracted 2 hr after mor-
phine treatment or 3 days after s.c. implantation of 25 mg morphine pellets as
described (Zachariou et al., 2003, 2006). Animals were housed in a 12 hr dark/
light cycle room according to the animal care and use committees of UT
Southwestern Medical Center and the University of Crete.
Place Conditioning, Analgesia, Locomotor Activity,
and Morphine Withdrawal Assays
An unbiased place conditioning procedure was performed as described in ear-
lier studies (Zachariou et al., 2006). Analgesia was measured using a 52C hot
plate test, as described before (Zachariou et al., 2006). Data are expressed as
%maximal possible effect (MPE = [Latency-baseline]/[cutoff latency]). For opi-
ate withdrawal assays, mice were injected with increasing morphine doses as
described (Zachariou et al., 2003), and withdrawal was precipitated after the
third day of injections using naloxone (1 mg/kg, s.c., Sigma). Withdrawal signs
were monitored for 25 min after naloxone administration. For the morphine
locomotor sensitization assays, mice were placed in locomotor activity cham-
bers as described earlier (Allen et al., 2006) and ambulatory activity was mon-
itored for 30 min after, saline (days 1–3) or morphine (days 4–9) injection.
Cell Culture and Immunocytochemistry
PC12 cells were grown in poly-lysine-coated coverslips in 6-well plates
in DMEM containing 10% fetal bovine serum, 5% horse serum, and 1%
Pen Strep (Invitrogen). Transfections with Spinophilin, HA-MOR, or control
pcDNA3 constructs were performed using Lipofectamine 2000 inOptimem (In-
vitrogen). Mouse embryonic fibroblasts from spinophilin wild-type and spino-
philin knockout day 14 embryos were grown in DMEM in 20% fetal bovine se-
rum and 1% Pen Strep (Invitrogen). For immunohistochemical studies cells,
were grown in four-chamber polystyrene vessel tissue culture-treated glass
slides (BD Biosciences) and infected with HSV HA-MOR virus (1:1000) in se-
rum-free DMEM. Cells were treated with morphine (10 mM) or vehicle 24 hr fol-
lowing transfection and then fixed in 4% formaldehyde in phosphate-buffered
saline (PBS) and incubated with IMF saponin (0.25% cold water fish gelatin,
0.02% saponin, 0.01%Na Azide in PBS) for 20moremin. Cells were then incu-
bated with an anti-HA mouse monoclonal antibody (1:1000, Sigma) for 45 min,
washed three times with PBS, then with Cy3-conjugated donkey anti-mouse
secondary antibody (1:500, Jackson Immunoresearch) for 20 min. Images
were acquired using a Leica confocal microscope with a 603 oil objective.
Quantitative Internalization Assay (ELISA)
PC12 cells, transfected with HA-MOR and Spinophilin (or control) constructs
or MEF cells infected with HSV-HA-MOR virus were incubated with mouse
anti-HA antibody (Sigma-Aldrich) for 2 hr in Optimem at 4C, as described be-
fore (Psifogeorgou et al., 2007). They were next treated with 5 mM DAMGO or
10 mM morphine in Optimem, for 30 min at 37C and incubated for 2 more hr
with peroxidase-conjugated anti-mouse antibody (1:1000, Jackson Immuno-research). Plates were developedwith ABTS (2,2-Azino-di-(3-ethylbenzthiazo-
line-6-sulfonic acid (Sigma). Ten to thirtyminutes later, 200 ml substrate of each
sample was transferred to a 96-well plate and analyzed at 405 nm in a micro-
plate reader.
Coimmunoprecipitation Assays
Striatal tissues of mice treated with saline, fentanyl, or morphine for 15 or
30 min were rapidly dissected in buffer containing 0.32 M sucrose, 1 mM
EDTA, 1 mM EGTA, and protease inhibitors. Lysates were precleared with
20 ml of G agarose beads (Roche) by 1–2 hr incubation at 4C. Supernatants
were then incubated overnight with primary antibody (anti-rabbit spinophilin,
1:1000) on a rotating platform, followed by incubation with 20 ml protein G
agarose beads for 2 hr at 4C. Beads were washed three times in lysis buffer,
precipitated, and resuspended in equal volume of loading buffer. Immunopre-
cipitated proteins were analyzed by 10.5% SDS-polyacrylamide gel electro-
phoresis followed by electrotransfer to nitrocellulose membrane 0.45 mm
(Bio-Rad Labs). Immunoblotting was performed with an rabbit anti-MOR anti-
body (Chemicon), or with a rabbit anti-Gb5 (C terminus) antibody (W. Simonds,
National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda MD)
or a rabbit anti-Gb (Santa Cruz) or rabbit anti-GRK2 (Santa Cruz, CA) or rabbit
anti-RGS9-2 (S. Gold, UT Southwestern Medical Center, Dallas, TX, and
T. Wensel, Baylor College of Medicine, Houston, TX) followed by incubation
with HRP-conjugated anti-mouse or HRP conjugated anti-rabbit antibody
(Sigma). Bands were visualized with enhanced chemiluminescence (Pierce
Biotechnology).
Primary Striatal Cultures
Striata were removed from 17- 18-day-old mouse embryos. Isolated tissue
was incubated for 20 min in 1 mM papain, 10 mM trypsin, 5000 U DNase I,
and dissociated with gentle mechanical trituration using an eppendorf pipette.
Cells were incubated in Neurobasal medium containing B-27 and l-glutamine.
Transfections were performed on day 12. Transfection of siRNA (spinophilin
siRNA sequence AACTCGAAGCTGGTCACTAAG) was performed using
Hi-Perfect transfection reagent (QIAGEN) as described by Wang et al.
(2004). A nontargeting siRNA (control nontargeting siRNA#1, Dharmacon)
was used as a control. Viral infections were performed 2 days after transfec-
tion. Twenty-four hours later, cells were treated with10 mM morphine for 30,
45, or 60 min and immunofluorescence was performed using a mouse anti-
HA monoclonal antibody (1:1000), as described earlier. Cells were visualized
using a Leica Microscope with a 603 objective.
Immunoblotting
Nucleus accumbens and dorsal striatal punches were dissected with a 12
gauge syringe needle from 1 mm thick coronal sections of mouse brain, and
immunoblotting was performed as described (Zachariou et al., 2003). The fol-
lowing antibodies were used: rabbit anti-spinophilin (1:10,000 dilution; Allen
et al., 1997), rabbit anti-neurabin (1:10,000 dilution; Muly et al., 2004), a mouse
anti-phospho-ERK antibody (1:10,000 dilution; Sigma), a rabbit anti-RGS4 an-
tibody (1:2000; S. Mumby, UT Southwestern Medical Center), a rabbit RGS9
antibody (1:5000; Psifogeorgou et al., 2007), a rabbit anti-Gb5 (C terminus)
antibody (1:10,000; W. Simonds, National Institute of Diabetes, Digestive
and Kidney Diseases, Bethesda, MD).
cAMP and [3H] DAMGO Binding Assays
Striata from naive wild-type and knockout mice were frozen at70C until use.
Adenylyl cyclase activity from striatal membranes wasmeasured as described
by Unterwald et al. (1993) with minor modifications. Briefly, membranes
(10 mg protein/10 ml) were treated with different concentrations of DAMGO
(0–10 mM) for 15min at 30C in an assay buffer containing a final concentration
of 80mM Tris, 10 mM theophylline, 1 mMMgSO4, 0.4 mMEGTA, 30mMNaCl,
0.25 mM ATP, 10 mM GDP (pH 7.4). Adenylyl cyclase activity was terminated
by placing tubes in boiling water for 2 min. To measure the amount of cAMP
formed, [3H]cAMP (final concentration 4 nM) in citrate-phosphate buffer (pH 4)
and 20 ml binding protein prepared from bovine adrenal glands were added to
each sample. The binding reaction was allowed to reach equilibrium by over-
night incubation at 4C. The assay was terminated by rapid filtration in a Bran-
del machine using GF/B filters. The filters were washed three times withNeuron 58, 238–247, April 24, 2008 ª2008 Elsevier Inc. 245
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Spinophilin Modulates Opiate Addictionice-cold 20 mM sodium phosphate buffer (pH 6) and bound radioactivity
measured in a liquid scintillation counter. Radioactivity was converted to pmol
of cAMP by comparison to the curve derived from the cAMP standards. For
binding assays striatal membranes from wild-type or spinophilin knockout an-
imals (50 mg protein) were treated with 10 nM [3H] DAMGO in 50 mM Tris-Cl
(pH 7.4) for 1 hr at 37C in the absence or presence of 1 mM cold DAMGO.
Viral-Mediated Gene Transfer In Vivo
AAV-spinophilin and AAV-GFP viruses were produced using a triple transfec-
tion helper free method in HEK cells and purified as described earlier (Hommel
et al., 2003; Zachariou et al., 2006). Stereotaxic coordinates for AAV vector
injections into the NAc were as follows: anteriorposterior +1.6 mm, lateral ±
1.5 mm, and dorsoventral4.5mm at an angle of 10 from the midline (relative
to Bregma).
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